ATRIPLA efavirenz emtricitabine and tenofovir disoproxil fumarate tablet film coated United States - English - NLM (National Library of Medicine)

atripla efavirenz emtricitabine and tenofovir disoproxil fumarate tablet film coated

avera mckennan hospital - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8) - efavirenz 600 mg

ATRIPLA- efavirenz, emtricitabine, and tenofovir disoproxil fumarate tablet, film coated United States - English - NLM (National Library of Medicine)

atripla- efavirenz, emtricitabine, and tenofovir disoproxil fumarate tablet, film coated

gilead sciences, llc - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8), emtricitabine (unii: g70b4etf4s) (emtricitabine - unii:g70b4etf4s), tenofovir disoproxil fumarate (unii: ott9j7900i) (tenofovir anhydrous - unii:w4hfe001u5) - efavirenz 600 mg - atripla® is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and pediatric patients weighing at least 40 kg. - atripla is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., stevens-johnson syndrome, erythema multiforme, or toxic skin eruptions) to efavirenz, a component of atripla [see warnings and precautions (5.2)] . - atripla is contraindicated to be coadministered with voriconazole or elbasvir/grazoprevir [see drug interactions (7.3) and clinical pharmacology (12.3)]. antiretroviral pregnancy registry there is a pregnancy exposure registry that monitors pregnancy outcomes in adults and adolescents exposed to atripla during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at (800) 258-4263. risk summary there are retrospective case reports of neural tube defects in infants whose mothers were e

ATRIPLA ACCESS- efavirenz, emtricitabine, and tenofovir disoproxil fumarate tablet, film coated United States - English - NLM (National Library of Medicine)

atripla access- efavirenz, emtricitabine, and tenofovir disoproxil fumarate tablet, film coated

gilead sciences, inc. - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8), emtricitabine (unii: g70b4etf4s) (emtricitabine - unii:g70b4etf4s), tenofovir disoproxil fumarate (unii: ott9j7900i) (tenofovir anhydrous - unii:w4hfe001u5) - efavirenz 600 mg - atripla™ is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and pediatric patients weighing at least 40 kg. - atripla is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., stevens-johnson syndrome, erythema multiforme, or toxic skin eruptions) to efavirenz, a component of atripla [see warnings and precautions (5.2)]. - atripla is contraindicated to be coadministered with voriconazole or elbasvir/grazoprevir [see drug interactions (7.3) and clinical pharmacology (12.3)]. antiretroviral pregnancy registry there is a pregnancy exposure registry that monitors pregnancy outcomes in adults and adolescents exposed to atripla during pregnancy. healthcare providers are encouraged to register patients who become pregnant on the worldwide web at www.apregistry.com/. risk summary there are retrospective case reports of neural tube defects in infants whose mothers were exposed to efv-conta

ATRIPLA- efavirenz, emtricitabine, and tenofovir disoproxil fumarate tablet, film coated United States - English - NLM (National Library of Medicine)

atripla- efavirenz, emtricitabine, and tenofovir disoproxil fumarate tablet, film coated

remedyrepack inc. - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8), emtricitabine (unii: g70b4etf4s) (emtricitabine - unii:g70b4etf4s), tenofovir disoproxil fumarate (unii: ott9j7900i) (tenofovir anhydrous - unii:w4hfe001u5) - efavirenz 600 mg - atripla ® is indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and pediatric patients weighing at least 40 kg. - atripla is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., stevens-johnson syndrome, erythema multiforme, or toxic skin eruptions) to efavirenz, a component of atripla [see warnings and precautions (5.2)] . - atripla is contraindicated to be coadministered with voriconazole or elbasvir/grazoprevir [see drug interactions (7.3) and clinical pharmacology (12.3)]. antiretroviral pregnancy registry there is a pregnancy exposure registry that monitors pregnancy outcomes in adults and adolescents exposed to atripla during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at (8

SYMFI LO efavirenz lamivudine and tenofovir disoproxil fumarate tablet film coated United States - English - NLM (National Library of Medicine)

symfi lo efavirenz lamivudine and tenofovir disoproxil fumarate tablet film coated

mylan laboratories limited - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8) - efavirenz 400 mg

Efavirenz Mylan 600 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

efavirenz mylan 600 mg film-coat. tabl.

viatris gx bv-srl - efavirenz 600 mg - film-coated tablet - 600 mg - efavirenz 600 mg - efavirenz

Efavirenz  600MG Emtricitabine 200MG and Tablet Kenya - English - Pharmacy and Poisons Board

efavirenz 600mg emtricitabine 200mg and tablet

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - efavirenz emtricitabine tenofovir disoproxil… - tablet - efavirenz 600mg emtricitabine 200mg tenofovir… - antivirals for systemic use: combinations of

Efavirenz 200MG TABLETS Kenya - English - Pharmacy and Poisons Board

efavirenz 200mg tablets

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - efavirenz usp - tablet - efavirenz 200mg - antivirals for systemic use: non-nucleoside

Efavirenz 600mg Tablets Kenya - English - Pharmacy and Poisons Board

efavirenz 600mg tablets

strides pharma science limited no 36/7, suragajakkanahalli, lndlavadi cross, - efavirenz usp - tablet - efavirenz 600mg - antivirals for systemic use: non-nucleoside